List of Excipients in Branded Drug COLGATE TOTAL DAILY REPAIR

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Colgate-Palmolive Company	COLGATE TOTAL DAILY REPAIR	sodium fluoride and triclosan	35000-168	BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER
Colgate-Palmolive Company	COLGATE TOTAL DAILY REPAIR	sodium fluoride and triclosan	35000-168	CARBOXYMETHYLCELLULOSE SODIUM
Colgate-Palmolive Company	COLGATE TOTAL DAILY REPAIR	sodium fluoride and triclosan	35000-168	CARRAGEENAN
Colgate-Palmolive Company	COLGATE TOTAL DAILY REPAIR	sodium fluoride and triclosan	35000-168	GLYCERIN
Colgate-Palmolive Company	COLGATE TOTAL DAILY REPAIR	sodium fluoride and triclosan	35000-168	HYDRATED SILICA

Colgate Total Daily Repair Excipient Strategy, Patent Position, and Commercial Opportunities

Last updated: September 24, 2026

Colgate Total Daily Repair is an OTC oral-care product rather than an FDA-approved pharmaceutical drug. Its commercial value depends on the interaction between an anticaries active ingredient, an abrasive-cleaning system, humectants, surfactants, flavor, rheology modifiers, and packaging. The strongest opportunities are differentiated low-abrasion formulations, stannous-fluoride stabilization, sensitive-teeth positioning, premium delivery formats, and regional regulatory adaptation.

What is Colgate Total Daily Repair?

Colgate Total Daily Repair is a daily-use toothpaste marketed under the Colgate Total platform. Product composition and active ingredients vary by country. U.S. products in the Colgate Total platform commonly use stannous fluoride or sodium fluoride under the FDA’s OTC oral-health framework. European and other markets may use sodium fluoride at approximately 1,450 ppm fluoride.

The product is generally positioned around:

• Cavity prevention
• Plaque and gingivitis control
• Enamel protection
• Sensitivity relief
• Fresh breath
• Daily whole-mouth protection

The regulatory classification is important. In the United States, toothpaste containing an anticaries active is generally regulated under the FDA’s OTC anticaries monograph rather than through an Orange Book-listed new drug application (FDA, 2021).

What are the likely active and inactive ingredients?

A typical Colgate Total Daily Repair formulation may contain the following functional groups:

Formulation component	Typical examples	Commercial function
Anticaries active	Sodium fluoride or stannous fluoride	Fluoride delivery and caries prevention
Abrasive	Hydrated silica	Cleaning, stain removal, polishing
Humectant	Glycerin, sorbitol, propylene glycol	Moisture retention and texture
Water phase	Purified water	Solvent and dispersion medium
Surfactant	Sodium lauryl sulfate, cocamidopropyl betaine	Foaming and soil removal
Rheology modifier	Cellulose gum, xanthan gum, carrageenan	Viscosity and suspension
Sweetener	Sodium saccharin, sucralose	Taste correction
Flavor	Mint oils, menthol, aroma compounds	Consumer acceptance and breath-freshening
Chelator or stabilizer	Sodium citrate, phosphate salts	pH control and mineral management
Preservative system	Depends on market and formula	Microbial control
Opacifier or colorant	Titanium dioxide or approved alternatives	Appearance

The precise ingredient declaration must be assessed against the label for the target jurisdiction. Ingredient order, active concentration, flavor system, and abrasive grade can change between U.S., European, Asian, and Latin American products.

What excipient strategy supports Colgate Total Daily Repair?

The excipient strategy should prioritize chemical stability, consumer sensory performance, fluoride availability, and low tissue irritation. Toothpaste is a complex semisolid dosage form. A formula can comply with the active-ingredient standard yet fail commercially if it separates, loses viscosity, tastes metallic, or produces excessive irritation.

How should the abrasive system be designed?

Hydrated silica is the central abrasive opportunity. The optimal silica system balances:

• Cleaning efficacy
• Enamel and dentin abrasivity
• Surface gloss
• Compatibility with fluoride
• Dispersion stability
• Mouthfeel
• Cost

A high-cleaning silica may improve stain removal but increase risk of dentin wear or consumer complaints. A lower-abrasion system is better aligned with “daily repair,” enamel protection, sensitivity, and long-term use claims.

Commercially attractive silica platforms include:

1. Low-RDA silica for daily-use formulas.
2. Dual-particle-size silica for cleaning and polishing.
3. Surface-treated silica with improved flavor release.
4. Silica systems optimized for stannous fluoride compatibility.
5. Calcium-free systems that reduce active-ingredient interaction.

The principal formulation risk is excessive binding or adsorption of fluoride or stannous ions onto the abrasive surface. Particle surface chemistry, moisture content, and pH can materially affect active availability.

How should humectants and rheology modifiers be selected?

Glycerin and sorbitol provide moisture retention, smoothness, and freeze-thaw stability. Glycerin can improve mouthfeel but may increase tackiness at high concentrations. Sorbitol can support sweetness and body while lowering formulation cost.

Cellulose gum, xanthan gum, and related polymers control:

• Extrusion from the tube
• Standing stability
• Phase separation
• Suspension of insoluble particles
• Post-brushing mouthfeel

A strong commercial formulation should maintain a uniform ribbon during storage and dispense without stringing. Polymer selection also affects flavor release and foaming. Excessive viscosity can reduce consumer perception of clean rinsing, while insufficient viscosity can cause syneresis or tube separation.

Which surfactants are commercially important?

Sodium lauryl sulfate remains an effective foaming and cleaning surfactant, but consumer demand for low-irritation and “free-from” formulations creates an opportunity for alternatives.

Candidate systems include:

• Cocamidopropyl betaine
• Sodium methyl cocoyl taurate
• Sodium lauroyl sarcosinate
• Sodium cocoyl glutamate
• Mild amphoteric blends

A surfactant replacement must preserve foam volume, flavor release, active stability, and cleaning perception. Low-SLS formulations can command a premium, particularly in sensitive-mouth, enamel-care, natural-positioned, and professional-dental channels.

What formulation patents could protect a Colgate Total Daily Repair strategy?

Protection is more likely to arise from formulation architecture than from basic fluoride use. Fluoride toothpaste chemistry has a crowded prior-art field, and core composition concepts are often vulnerable to obviousness attacks.

Potentially protectable areas include:

Patent target	Potential claim focus	Relative commercial value
Stannous-fluoride stabilization	Stabilizer combination, pH range, oxygen control	High
Low-abrasion silica system	Particle morphology, RDA, surface treatment	High
Multi-active delivery	Fluoride with desensitizing or antibacterial agents	High
Flavor masking	Metallic-note reduction and controlled release	Medium
Polymer network	Dispensing, suspension, and phase stability	Medium
Packaging	Barrier tube, oxygen control, moisture protection	Medium
Manufacturing process	Order of addition, deaeration, controlled mixing	Medium
Sensitive-teeth formulation	Low-irritation surfactant and active combination	High

Claims should be drafted around measurable parameters rather than broad ingredient lists. Examples include fluoride recovery after aging, stannous-ion availability, RDA range, viscosity profile, phase stability, peroxide compatibility, or sensory-panel results.

How strong is the patent estate for the product?

The product-specific patent position is likely weaker than the broader Colgate Total platform estate unless Colgate-Palmolive has active patents covering a particular stabilization system, abrasive combination, delivery package, or manufacturing process.

Core sodium-fluoride toothpaste claims generally face substantial prior art. Stannous-fluoride formulations may offer stronger opportunities because oxidation, taste, staining, compatibility, and bioavailability create technical problems that can support narrower claims.

A competitor evaluating entry should separate four layers:

1. Active-ingredient rights.
2. Formulation rights.
3. Manufacturing-process rights.
4. Packaging and trade-dress rights.

The first layer may be expired or unavailable. The second and third layers can remain commercially relevant even when the active ingredient is unprotected. Trade dress, trademarks, and consumer recognition may create practical barriers that are separate from patent protection.

When does Colgate Total Daily Repair lose exclusivity?

Colgate Total Daily Repair does not have a single pharmaceutical exclusivity date comparable to an NDA product. OTC monograph compliance allows competing products to enter without waiting for an Orange Book patent expiration, provided they satisfy applicable regulatory requirements.

What is the Orange Book status of Colgate Total Daily Repair?

A standard OTC toothpaste marketed under the anticaries monograph is generally not listed in the Orange Book as an NDA or ANDA product. The product therefore does not ordinarily have:

• Orange Book patent listings
• Hatch-Waxman five-year NCE exclusivity
• Paragraph IV certification requirements
• ANDA approval tied to the brand’s listing

The FDA’s anticaries monograph identifies permitted active ingredients, concentrations, labeling, and conditions of use. Sodium fluoride and stannous fluoride are among the relevant actives for anticaries toothpaste products under the applicable regulatory framework (FDA, 2021).

Are Paragraph IV challenges relevant?

Paragraph IV litigation is generally not the primary entry mechanism for a monograph-compliant toothpaste. A private-label or branded competitor can develop a compliant product without certifying against Colgate patents in the same way an ANDA applicant would challenge an Orange Book-listed pharmaceutical.

Patent litigation can still arise over:

• A specific stabilized fluoride formulation
• A branded delivery device
• A manufacturing process
• A packaging configuration
• Trade dress
• Advertising claims
• Trademark infringement

The more likely competitive path is independent formulation development followed by OTC regulatory review, label substantiation, and commercial launch.

What generic entry risks exist?

The entry risk is high for basic sodium-fluoride toothpaste and moderate for technically differentiated products.

Entry category	Risk to Colgate Total Daily Repair	Main barrier
Basic fluoride toothpaste	High	Low technical and regulatory complexity
Premium low-abrasion formula	Moderate	Abrasive optimization and sensory testing
Stannous-fluoride equivalent	Moderate	Stability, taste, staining, and compatibility
Sensitive-teeth product	Moderate	Clinical support and consumer trust
Low-SLS or natural-positioned product	High	Formulation know-how is accessible
Novel package or dispenser	Lower	Tooling, supply chain, and brand recognition
Product with patented manufacturing process	Lower	Process replication and freedom-to-operate

Retailer private labels can compete on price. Dental brands can compete on professional endorsement. Mass-market competitors can compete through whitening, sensitivity, natural ingredients, or sustainability claims.

What manufacturing and IP barriers affect the product?

The main manufacturing barriers are process-control barriers rather than active pharmaceutical ingredient barriers.

Critical manufacturing variables include:

• Order of ingredient addition
• Hydration time for polymers
• Silica dispersion
• Vacuum deaeration
• pH control
• Moisture management
• Active premix uniformity
• Tube-filling accuracy
• Compatibility between formula and laminate packaging

Stannous fluoride presents more demanding stability requirements than sodium fluoride because stannous ions can oxidize and can contribute to metallic taste or staining under poorly controlled conditions. Stabilizer systems, oxygen exposure, water activity, and packaging-barrier performance can therefore support both know-how and patent claims.

Contract manufacturers with established toothpaste equipment can produce a basic equivalent. They may not reproduce the exact stability, flavor, dispensing, and shelf-life profile without process development.

What commercial opportunities exist for excipient suppliers?

The largest opportunities are in specialty excipients that solve a specific performance problem.

Low-abrasion silica

Silica suppliers can pursue premium systems with controlled RDA, lower dentin wear, high cleaning efficiency, and improved compatibility with fluoride actives. Dental sensitivity and enamel erosion support the commercial case.

Mild surfactant systems

SLS-free or reduced-SLS systems can target consumers seeking lower irritation. The opportunity is strongest when the formulation retains foam and clean-mouth perception.

Fluoride-stabilizing excipients

Stabilizer combinations that preserve soluble fluoride or stannous-ion availability can support premium pricing. Suppliers need data on active recovery, accelerated aging, taste, and staining.

Natural and biodegradable polymers

Cellulose derivatives, starch-based polymers, and fermentation-derived thickeners can support “naturally derived” and sustainability claims. Their limits are cost, microbial control, and consistent rheology.

Flavor encapsulation

Encapsulated mint, menthol, and cooling agents can improve storage stability and provide a staged sensory profile. Controlled flavor release may reduce the need for high flavor loading and help mask metallic notes.

Packaging-linked formulation systems

Barrier tubes, reduced-plastic structures, and recyclable packages create opportunities for excipient-package co-development. Formulations may need adjustment because packaging changes can alter water loss, oxygen exposure, and flavor migration.

How does Colgate Total Daily Repair compare with competing products?

Brand platform	Typical differentiation	Excipient opportunity
Colgate Total	Whole-mouth protection and daily maintenance	Stabilized active, low-abrasion silica, mild surfactants
Sensodyne	Sensitivity management	Desensitizer compatibility and low-irritation base
Crest Pro-Health	Broad protection and stannous fluoride positioning	Stannous stabilization and stain control
Parodontax	Gum health and high-bicarbonate positioning	Abrasive balance, flavor masking, rheology
Natural toothpaste brands	Ingredient simplicity and low-SLS claims	Alternative surfactants, natural polymers, mineral systems

The most defensible excipient opportunity is not a generic “better toothpaste” claim. It is a formulation that delivers a measurable benefit, such as reduced dentin abrasion, higher soluble fluoride after aging, improved stannous stability, or lower irritation at equivalent cleaning performance.

What regulatory status affects commercialization?

For the United States, the principal route is compliance with the FDA OTC anticaries monograph and applicable labeling requirements. Products sold in the European Union may fall under a combination of cosmetic and medicinal-product rules depending on the claims, active ingredients, and national implementation. A toothpaste marketed only for cleansing may be treated differently from one making therapeutic disease-treatment claims.

Commercial teams should control claims carefully. “Helps protect against cavities” is distinct from a claim that the product treats periodontal disease or repairs damaged enamel. The latter may trigger more demanding substantiation or a different regulatory classification.

Key Takeaways

• Colgate Total Daily Repair is an OTC toothpaste platform, not a conventional Orange Book pharmaceutical.
• The highest-value excipient opportunities involve silica abrasivity, fluoride stabilization, mild surfactants, flavor masking, and polymer rheology.
• Basic fluoride toothpaste has high generic and private-label entry risk.
• Stannous-fluoride formulations have stronger technical barriers because of oxidation, taste, staining, and active-availability issues.
• Product exclusivity is driven mainly by formulation patents, manufacturing know-how, trademarks, trade dress, and brand equity rather than pharmaceutical regulatory exclusivity.
• A commercially strong formulation patent should claim measurable performance parameters, not only broad ingredient combinations.
• Packaging is part of the stability system and can support both product performance and IP differentiation.
• The strongest excipient suppliers will provide formulation data tied to consumer outcomes, including low abrasion, active recovery, mouthfeel, and shelf life.

FAQs

Is Colgate Total Daily Repair a pharmaceutical drug?

It is generally an OTC oral-care product regulated through anticaries requirements rather than an FDA-approved prescription or NDA drug pathway.

Does Colgate Total Daily Repair have an Orange Book patent?

A monograph-compliant toothpaste normally does not have an Orange Book listing. Any relevant protection would more likely involve formulation, manufacturing, packaging, trademark, or trade-dress rights.

Which excipient is most important in Colgate Total Daily Repair?

Hydrated silica is a central excipient because it affects cleaning, polishing, abrasivity, fluoride compatibility, and mouthfeel.

Why is stannous fluoride harder to formulate than sodium fluoride?

Stannous fluoride is more sensitive to oxidation and can create taste, staining, and compatibility challenges. Stabilizer selection and oxygen control are therefore more important.

Can a private-label manufacturer launch a competing product?

Yes, if the product complies with applicable OTC and labeling requirements and avoids protected formulation, process, packaging, trademark, and trade-dress rights.

References

1. Colgate-Palmolive Company. (2024). Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Colgate-Palmolive Company.

2. U.S. Food and Drug Administration. (2021). OTC Monograph M021: Anticaries drug products for over-the-counter human use. U.S. Department of Health and Human Services.

3. U.S. Food and Drug Administration. (2024). Drug products marketed under the OTC monograph system. U.S. Department of Health and Human Services.

4. U.S. Food and Drug Administration. (2024). 21 C.F.R. Part 355: Anticaries drug products for over-the-counter human use. U.S. Department of Health and Human Services.

5. European Parliament and Council of the European Union. (2009). Regulation (EC) No. 1223/2009 on cosmetic products. Official Journal of the European Union.